Daewon Pharmaceutical Co., Ltd. (KRX:003220)

South Korea · Delayed Price · Currency is KRW

10,300

+70 (0.68%)

At close: Apr 10, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Restrictions			500.70B	452.80B	339.08B	306.36B	315.31B
Restrictions Growth			10.58%	33.54%	10.68%	-2.84%	11.19%
Health Functional Food			26.48B	25.86B	13.07B	-	-
Health Functional Food Growth			2.39%	97.94%	-	-	-
Consolidated Adjustments			-521.20M	-1.07B	-155.22M	-57.52M	-413.29M
Hearing Aid			295.28M	1.29B	2.19B	2.20B	2.93B
Hearing Aid Growth			-77.04%	-41.25%	-0.50%	-24.96%	-12.64%
Total			526.95B	478.88B	354.18B	308.50B	317.83B
Total Growth			10.04%	35.21%	14.81%	-2.93%	10.88%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea			516.43B	467.17B	343.62B	299.16B	308.97B
South Korea Growth			10.54%	35.96%	14.86%	-3.18%	11.06%
Overseas			10.53B	11.71B	10.56B	9.34B	8.85B
Overseas Growth			-10.15%	10.93%	13.08%	5.50%	4.85%
Total			526.95B	478.88B	354.18B	308.50B	317.83B
Total Growth			10.04%	35.21%	14.81%	-2.93%	10.88%

Source: S&P Global Market Intelligence.